Plain-English translation of NCT06800898 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers want to understand whether a gene called orexin — which normally helps control hunger and sleep — works differently in people with anorexia nervosa. This study will compare blood samples from women hospitalized with anorexia nervosa to healthy women of the same age to see if the orexin gene is 'turned on' or 'turned off' differently in each group.
Anorexia nervosa is a serious eating disorder, and researchers don't fully understand all the biological reasons why it develops. This study aims to find a new piece of that puzzle by examining whether changes in the orexin gene might play a role — which could eventually lead to better treatments.
You likely qualify if…
You likely don't qualify if…
If you are in the anorexia nervosa group, you are already hospitalized at the study site and would provide a blood sample as part of your care. If you are in the healthy comparison group, you would visit the research site to provide a blood sample and possibly answer questions about your eating, mood, and sleep. The study will use your blood sample to examine the orexin gene and compare it between the two groups.
AI-generated summary from trial data · Jun 20, 2026 · Not medical advice
Italy
Enrollment target
~60 participants
Started
June 2024
Primary completion
June 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Alessandro Sartorio, MD
Istituto Auxologico Italiano
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.